...
首页> 外文期刊>Journal of experimental & clinical cancer research : >Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo
【24h】

Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo

机译:敲除核小体结合蛋白1抑制体外和体内透明细胞肾细胞癌细胞的生长和侵袭

获取原文
           

摘要

Background The nucleosome binding protein 1 (HMGN5/NSBP1) is a member of the HMGN protein family and is highly expressed in several kinds of cancer. Nevertheless, the role of NSBP1 in clear cell renal cell carcinoma (ccRCC) remains unclear. This study aimed to confirm the oncogenic role of NSBP1 in ccRCC using in vitro and in vivo models and explore the mechanism by which NSBP1 contributes to ccRCC tumorigenesis. Methods NSBP1 expression was detected in renal tissues from 152 ccRCC patients by immunohistochemistry, and examined in ccRCC cell lines by RT-PCR and Western blot analysis. ccRCC cells were transfected by NSBP1 RNAi and cell viability, apoptosis and invasion were detected by cell vitality test, flow cytometry and transwell assay in vitro. Xenograft in nude mice was also employed to examine the tumorigenesis of ccRCC cells depleted of NSBP1. Results Immunohistostaining showed strong immunoreactivity of NSBP1 in all ccRCC tissues and NSBP1 expression level was associated with tumor grade (p = 0.04). NSBP1 expression at mRNA and protein levels was high in ccRCC cell lines. Knockdown of NSBP1 induced cell cycle arrest and apoptosis, and inhibited invasion in 786-O cells. Western blot analysis demonstrated increased expression of Bax and decreased expression of Bcl-2, CyclinB1, VEGF, VEGFR-2, MMP-2, MMP-9, c-fos and c-jun in 786-O cells depleted of NSBP1. In vivo study further showed that knockdown of NSBP1 affected the tumorigenesis of ccRCC cells in nude mice. Conclusions NSBP1 plays oncogenic role in ccRCCs by promoting cell proliferation and invasion, and could be exploited as a target for ccRCC treatment.
机译:背景技术核小体结合蛋白1(HMGN5 / NSBP1)是HMGN蛋白家族的成员,并在多种癌症中高度表达。尽管如此,NSBP1在透明细胞肾细胞癌(ccRCC)中的作用仍不清楚。这项研究旨在通过体外和体内模型确认NSBP1在ccRCC中的致癌作用,并探讨NSBP1促成ccRCC肿瘤发生的机制。方法采用免疫组织化学方法在152例ccRCC患者的肾组织中检测NSBP1的表达,并通过RT-PCR和Western blot分析检测其在ccRCC细胞中的表达。 ccRCC细胞经NSBP1 RNAi转染后,通过细胞活力试验,流式细胞术和transwell法检测细胞活力,凋亡和侵袭。裸鼠体内的异种移植也被用于检查耗尽NSBP1的ccRCC细胞的肿瘤发生。结果免疫组织染色显示在所有ccRCC组织中NSBP1具有很强的免疫反应性,且NSBP1表达水平与肿瘤等级有关(p = 0.04)。 ccRCC细胞系中mRNA和蛋白水平的NSBP1表达很高。抑制NSBP1诱导细胞周期停滞和凋亡,并抑制786-O细胞的侵袭。 Western印迹分析表明,在耗尽NSBP1的786-O细胞中,Bax的表达增加,而Bcl-2,CyclinB1,VEGF,VEGFR-2,MMP-2,MMP-9,c-fos和c-jun的表达降低。体内研究进一步表明,敲除NSBP1会影响裸鼠中ccRCC细胞的肿瘤发生。结论NSBP1通过促进细胞增殖和侵袭而在ccRCC中发挥致癌作用,可作为ccRCC治疗的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号